Literature DB >> 27197196

Constitutive Activation of PI3K in Oocyte Induces Ovarian Granulosa Cell Tumors.

So-Youn Kim1, Katherine Ebbert2, Marilia H Cordeiro2, Megan M Romero2, Kelly A Whelan2, Adrian A Suarez3, Teresa K Woodruff2, Takeshi Kurita4.   

Abstract

Cell-cell interactions play crucial roles in the maintenance of tissue homeostasis, a loss of which often leads to varying diseases, including cancer. Here, we report that uncontrolled PI3K activity within oocytes irreversibly transforms granulosa cells (GC), causing GC tumors (GCT) through perturbed local cell communication. Previously, we reported reproductive phenotypes of transgenic mice, in which expression of constitutively active mutant PI3K was induced in primordial oocytes by Gdf9-iCre. The transgenic mice (Cre(+)) demonstrated severe ovarian phenotypes, including the overgrowth of excess ovarian follicles and anovulation. Surprisingly, the Cre(+) mice became cachectic by postnatal day 80 due to bilateral GCT. Although GCT cells proliferated independently of oocytes, local interactions with mutant PI3K-positive oocytes during early folliculogenesis were essential for the GC transformation. Growing GCT cells expressed high levels of inhibin βA and nuclear SMAD3, and the proliferation rate was positively correlated with a high activin A to inhibin A ratio. These results suggested that the tumor cells stimulated their growth through an activin A autocrine signaling pathway, a hypothesis confirmed by activin A secretion in cultured GCT cells, which proliferated in response. Although communication between the oocyte and surrounding somatic cells is critical for the normal development of ovarian follicles, perturbations in oocyte-GC communication during early folliculogenesis can induce GCT by activating an autocrine growth circuit program in GC. Cancer Res; 76(13); 3851-61. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27197196      PMCID: PMC5081136          DOI: 10.1158/0008-5472.CAN-15-3358

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  50 in total

1.  Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  N Reed; D Millan; R Verheijen; M Castiglione
Journal:  Ann Oncol       Date:  2010-05       Impact factor: 32.976

Review 2.  Bone morphogenetic protein signaling transcription factor (SMAD) function in granulosa cells.

Authors:  Stephanie A Pangas
Journal:  Mol Cell Endocrinol       Date:  2011-07-07       Impact factor: 4.102

3.  The gametic synapse: RNA transfer to the bovine oocyte.

Authors:  Angus D Macaulay; Isabelle Gilbert; Julieta Caballero; Rodrigo Barreto; Eric Fournier; Prudencio Tossou; Marc-André Sirard; Hugh J Clarke; Édouard W Khandjian; Francois J Richard; Poul Hyttel; Claude Robert
Journal:  Biol Reprod       Date:  2014-08-20       Impact factor: 4.285

4.  Follistatin is a modulator of gonadal tumor progression and the activin-induced wasting syndrome in inhibin-deficient mice.

Authors:  S C Cipriano; L Chen; T R Kumar; M M Matzuk
Journal:  Endocrinology       Date:  2000-07       Impact factor: 4.736

5.  Cell autonomous phosphoinositide 3-kinase activation in oocytes disrupts normal ovarian function through promoting survival and overgrowth of ovarian follicles.

Authors:  So-Youn Kim; Katherine Ebbert; Marilia H Cordeiro; Megan Romero; Jie Zhu; Vanida Ann Serna; Kelly A Whelan; Teresa K Woodruff; Takeshi Kurita
Journal:  Endocrinology       Date:  2015-01-16       Impact factor: 4.736

6.  Serum Müllerian Inhibiting Substance/anti-Müllerian hormone levels in patients with adult granulosa cell tumors directly correlate with aggregate tumor mass as determined by pathology or radiology.

Authors:  Henry L Chang; Nima Pahlavan; Elkan F Halpern; David T MacLaughlin
Journal:  Gynecol Oncol       Date:  2009-04-08       Impact factor: 5.482

7.  Dominant-stable beta-catenin expression causes cell fate alterations and Wnt signaling antagonist expression in a murine granulosa cell tumor model.

Authors:  Derek Boerboom; Lisa D White; Sophie Dalle; José Courty; Joanne S Richards
Journal:  Cancer Res       Date:  2006-02-15       Impact factor: 12.701

8.  SMAD3 regulates gonadal tumorigenesis.

Authors:  Qinglei Li; Jonathan M Graff; Anne E O'Connor; Kate L Loveland; Martin M Matzuk
Journal:  Mol Endocrinol       Date:  2007-06-26

Review 9.  Management of ovarian stromal cell tumors.

Authors:  Nicoletta Colombo; Gabriella Parma; Vanna Zanagnolo; Alessandra Insinga
Journal:  J Clin Oncol       Date:  2007-07-10       Impact factor: 44.544

10.  Differential oocyte-specific expression of Cre recombinase activity in GDF-9-iCre, Zp3cre, and Msx2Cre transgenic mice.

Authors:  Zi-Jian Lan; Xueping Xu; Austin J Cooney
Journal:  Biol Reprod       Date:  2004-06-23       Impact factor: 4.285

View more
  18 in total

Review 1.  Lessons from bioengineering the ovarian follicle: a personal perspective.

Authors:  Teresa K Woodruff
Journal:  Reproduction       Date:  2019-12       Impact factor: 3.906

2.  A novel mouse model of testicular granulosa cell tumors.

Authors:  Xin Fang; Nan Ni; Yang Gao; David F Vincent; Laurent Bartholin; Qinglei Li
Journal:  Mol Hum Reprod       Date:  2018-07-01       Impact factor: 4.025

Review 3.  Adult-type granulosa cell tumor of the ovary.

Authors:  Xiuwen Li; Bo Tian; Mengyan Liu; Chunlei Miao; Di Wang
Journal:  Am J Cancer Res       Date:  2022-08-15       Impact factor: 5.942

4.  Continuous treatment with cisplatin induces the oocyte death of primordial follicles without activation.

Authors:  Maya Eldani; Yi Luan; Pauline C Xu; Tom Bargar; So-Youn Kim
Journal:  FASEB J       Date:  2020-08-23       Impact factor: 5.191

Review 5.  Ovarian Cancers: Genetic Abnormalities, Tumor Heterogeneity and Progression, Clonal Evolution and Cancer Stem Cells.

Authors:  Ugo Testa; Eleonora Petrucci; Luca Pasquini; Germana Castelli; Elvira Pelosi
Journal:  Medicines (Basel)       Date:  2018-02-01

6.  New Insights into the Role of Phosphoinositide 3-Kinase Activity in the Physiology of Immature Oocytes: Lessons from Recent Mouse Model Studies.

Authors:  So-Youn Kim; Takeshi Kurita
Journal:  Eur Med J Reprod Health       Date:  2018-06-07

7.  Disruption of postnatal folliculogenesis and development of ovarian tumor in a mouse model with aberrant transforming growth factor beta signaling.

Authors:  Yang Gao; Xin Fang; David F Vincent; David W Threadgill; Laurent Bartholin; Qinglei Li
Journal:  Reprod Biol Endocrinol       Date:  2017-12-08       Impact factor: 5.211

8.  MicroRNA profiling of ovarian granulosa cell tumours reveals novel diagnostic and prognostic markers.

Authors:  Andrew N Shelling; Cherie Blenkiron; Wei-Tzu Cheng; Roseanne Rosario; Anita Muthukaruppan; Michelle K Wilson; Kathryn Payne; Peter C Fong
Journal:  Clin Epigenetics       Date:  2017-07-21       Impact factor: 6.551

Review 9.  Potential roles of experimental reproductive technologies in infertile women with diminished ovarian reserve.

Authors:  Zexu Jiao; Orhan Bukulmez
Journal:  J Assist Reprod Genet       Date:  2021-06-07       Impact factor: 3.357

Review 10.  SMAD3 Activation: A Converging Point of Dysregulated TGF-Beta Superfamily Signaling and Genetic Aberrations in Granulosa Cell Tumor Development?

Authors:  Xin Fang; Yang Gao; Qinglei Li
Journal:  Biol Reprod       Date:  2016-09-28       Impact factor: 4.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.